Literature DB >> 30711707

The effects of perfluorooctanoate on high fat diet induced non-alcoholic fatty liver disease in mice.

Xilin Li1, Zemin Wang1, James E Klaunig2.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is affecting up to one-third of the general population in western countries. While the major cause of NAFLD is related to an unhealthy lifestyle, recent evidence has shown a role of chemical exposure in the induction and progression of NAFLD. Perfluorooctanoate (PFOA) is a ubiquitous environmental contaminant that exerts its hepatotoxicity mainly through the activation of peroxisome proliferator-activated receptor α (PPARα). We examined how PFOA might affect the progression of NAFLD and whether a preexisting fatty liver intensified or alleviated the effects of PFOA in the livers. As such, male C57BL/6 mice were fed with a low-fat control diet (CD) or a high fat diet (HFD) for 16 weeks to model normal or steatotic livers, respectively. Mice were then administered with PFOA (1mg/kg/d) by oral gavage for an additional 2, 8, and 16 weeks. Dietary treatment was continued throughout the whole study. We found HFD induced hepatic steatosis, lobular inflammation, and progressive fibrosis in mice. As expected, PFOA activated PPARα, constitutive androstane receptor (CAR) and pregnane X receptor (PXR), regardless of the diet. Gene expression analysis showed the interactions between HFD and PFOA on hepatic nuclear receptors were time-dependent. Hepatocytes growth as measured by DNA synthesis and cell growth genes induced by PFOA were exacerbated in the HFD group after 2 weeks, along with the enhanced activation of PPARα. In contrast, PFOA decreased the severity of hepatic steatosis. In HFD-fed mice, the hepatic triglyceride levels were reduced to 75%, 47%, and 40%, after 2, 8, and 16 weeks of PFOA treatment, respectively, compared to vehicle controls. Transcriptomic analysis showed the preexisting NAFLD enhanced PFOA related lipid oxidation pathways in mice. HFD induced hepatic fibrosis as measured by collagen staining and fibrosis gene markers were also attenuated by PFOA. Taken together, this study demonstrated that the preexisting NAFLD might impact on many biological effects induced by PFOA and thus need to be carefully considered as a factor in risk assessment.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30711707     DOI: 10.1016/j.tox.2019.01.017

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  14 in total

1.  Phase 0 of the Xenobiotic Response: Nuclear Receptors and Other Transcription Factors as a First Step in Protection from Xenobiotics.

Authors:  William S Baldwin
Journal:  Nucl Receptor Res       Date:  2019-11-20

2.  Predicting the effects of per- and polyfluoroalkyl substance mixtures on peroxisome proliferator-activated receptor alpha activity in vitro.

Authors:  Greylin Nielsen; Wendy J Heiger-Bernays; Jennifer J Schlezinger; Thomas F Webster
Journal:  Toxicology       Date:  2021-11-04       Impact factor: 4.221

3.  The role of maternal high fat diet on mouse pup metabolic endpoints following perinatal PFAS and PFAS mixture exposure.

Authors:  Emily S Marques; Juliana Agudelo; Emily M Kaye; Seyed Mohamad Sadegh Modaresi; Marisa Pfohl; Jitka Bečanová; Wei Wei; Marianne Polunas; Michael Goedken; Angela L Slitt
Journal:  Toxicology       Date:  2021-08-28       Impact factor: 4.571

4.  An 'Omics Approach to Unraveling the Paradoxical Effect of Diet on Perfluorooctanesulfonic Acid (PFOS) and Perfluorononanoic Acid (PFNA)-Induced Hepatic Steatosis.

Authors:  Marisa Pfohl; Emily Marques; Adam Auclair; Benjamin Barlock; Rohitash Jamwal; Michael Goedken; Fatemeh Akhlaghi; Angela L Slitt
Journal:  Toxicol Sci       Date:  2021-04-12       Impact factor: 4.849

5.  Development of an oral reference dose for the perfluorinated compound GenX.

Authors:  Chad M Thompson; Seneca E Fitch; Caroline Ring; William Rish; John M Cullen; Laurie C Haws
Journal:  J Appl Toxicol       Date:  2019-06-18       Impact factor: 3.446

6.  Acute PFOA exposure promotes epigenomic alterations in mouse kidney tissues.

Authors:  Faizan Rashid; Anujaianthi Ramakrishnan; Christopher Fields; Joseph Irudayaraj
Journal:  Toxicol Rep       Date:  2020-01-02

Review 7.  Metabolism-Disrupting Chemicals and the Constitutive Androstane Receptor CAR.

Authors:  Jenni Küblbeck; Jonna Niskanen; Paavo Honkakoski
Journal:  Cells       Date:  2020-10-15       Impact factor: 6.600

8.  Pharmacokinetic profile of Perfluorobutane Sulfonate and activation of hepatic nuclear receptor target genes in mice.

Authors:  Christopher Lau; Jason Rumpler; Kaberi P Das; Carman R Wood; Judith E Schmid; Mark J Strynar; John F Wambaugh
Journal:  Toxicology       Date:  2020-06-10       Impact factor: 4.571

9.  Effects of Curcumin in a Mouse Model of Very High Fat Diet-Induced Obesity.

Authors:  Iurii Koboziev; Shane Scoggin; Xiaoxia Gong; Parvin Mirzaei; Masoud Zabet-Moghaddam; Mohammad Yosofvand; Hanna Moussa; Yava Jones-Hall; Naima Moustaid-Moussa
Journal:  Biomolecules       Date:  2020-09-25

10.  The effect of endurance training on non-alcoholic fatty liver disease in mice.

Authors:  Luma Melo; Merve Bilici; Amit Hagar; James E Klaunig
Journal:  Physiol Rep       Date:  2021-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.